Ford is reassessing its EV plans, including vertical battery integration

Ford is reassessing its EV plans, including vertical battery integration


A Ford Mustang Mach-E GT compact sports utility vehicle during the 2022 New York International Auto Show in New York on April 14, 2022.

Michael Nagle | Bloomberg | Getty Images

DETROIT — Ford Motor is rethinking its electric vehicle strategies, including “reassessing” the need for vertical integration of batteries, CEO Jim Farley said Tuesday.

The Detroit automaker previously confirmed plans to delay or cut $12 billion in spending on all-electric vehicles, but the comments made Tuesday are the most detailed about Ford’s changing plans for EVs, sales of which are growing at a slower-than-expected rate.

“One of the things we’re taking advantage of in taking some timing delays is rationalizing the level and timing of our battery capacity to match demand and actually reassessing the vertical integration that we’re relying on, and betting on new chemistries and capacities,” Farley said during the automaker’s fourth-quarter earnings call.

Farley reiterated the company still believes EVs will grow, but noted widespread adoption for mass-market consumers won’t happen until the costs are more in line with traditional vehicles. EVs are typically thousands of dollars more expensive than their gas-powered counterparts.

Ford Chief Financial Officer John Lawler said in addition to reassessing the vertical integration in new battery chemistries, the company is further looking into adjusting installed production capacity to match demand and potentially delaying next-generation EVs to “to ensure they meet our criteria for profitability, given the new market reality.”

The company’s EV business, known as Model e, lost $4.7 billion last year, including $1.57 billion during the fourth quarter of 2023, offset by profits in the company’s fleet and traditional internal combustion engine units. Both businesses earned more than $7 billion each last year.

Lawler said Tuesday that the unit will have to stand on its own “sooner rather than later.”

He also said the company is pulling a target for its EV unit that called for 8% margin by 2026. The company had already set a target of two million vehicles sold annually by that time.

As Ford pulls back and reevaluates the EV business, it intends to lean in on sales of hybrid vehicles, specifically trucks. The company expects its hybrid sales to increase 40% this year. It sold 133,743 hybrid vehicles in the U.S. in 2023.

Don’t miss these stories from CNBC PRO:



Source

WNBPA President Nneka Ogwumike says new CBA will have a major impact on players’ bank accounts
Business

WNBPA President Nneka Ogwumike says new CBA will have a major impact on players’ bank accounts

The Women’s National Basketball Player’s Association ratified the terms of a new collective bargaining agreement Monday, calling it “transformational” and “bigger than basketball.” The new CBA begins this season and runs through 2032. When asked her opinion of the most important outcome from the deal, WNBPA President Nneka Ogwumike had two words: “Bank accounts.” “Being […]

Read More
Toyota to invest  billion to increase U.S. production in Kentucky, Indiana plants
Business

Toyota to invest $1 billion to increase U.S. production in Kentucky, Indiana plants

Production of the Toyota Camry at the automaker’s plant in Georgetown, Kentucky. Courtesy Toyota Toyota Motor on Monday announced it would spend $1 billion at two U.S. plants as part of a plan to invest up to $10 billion domestically over the next five years. The new investments include $800 million at a plant in […]

Read More
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
Business

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a Lyme disease vaccine candidate despite the shot failing a late-stage trial. Pfizer said the vaccine missed the trial’s statistical goal because not enough people in the study contracted Lyme disease to be confident in the results. Still, […]

Read More